Table VI.2

Table VI.2: The Number of States That Reported Communication and Interactions with Other State Pharmacy Regulatory Bodies, and How These States Rated the Helpfulness of This Communication and Interaction
	Number of states that reported having communication or interaction	How states that reported having communication or interaction rated the helpfulness of this communication or interaction
Type of communication or interaction with other state pharmacy regulatory bodies		Very or moderately helpful	Slightly or not at all helpful	Don't know
National associations (e.g., National Association of Boards of Pharmacy conferences, annual national association meetings)	39^a	34	3	1
Regional associations (e.g., conferences or regional meetings)	26	22	4	0
State-to-state direct communication (e.g., in-person meetings, phone calls and/or emails with other state boards of pharmacy)	34	33	1	0
Conduct joint inspections with other state boards of pharmacy or other state pharmacy regulatory bodies	9	8	1	0
Informal networking with other states that takes place at events sponsored by the Food and Drug Administration or industry	33	32	1	0
Other types of interactions (e.g., meetings with state boards of pharmacy and state associations)	6	6	0	0

^{Source: GAO survey of state pharmacy regulatory bodies, survey question 39. | GAO-17-363SP}

Notes: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.

^aOne of the 39 states did not indicate a level of helpfulness of national association meetings.